Cargando…

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease

BACKGROUND: Low-dose oral azithromycin therapy is recommended as a preventive treatment for acute exacerbations of COPD. However, the overall benefit–harm balance of this treatment has not been well studied. METHODS: A probabilistic Markov model of COPD was created to simulate the course of COPD ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmadian, Safa, Sin, Don D, Lynd, Larry, Harrison, Mark, Sadatsafavi, Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606520/ https://www.ncbi.nlm.nih.gov/pubmed/34836921 http://dx.doi.org/10.1136/thoraxjnl-2021-217962

Ejemplares similares

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease
por: Nishimura, Koichi, et al.
Publicado: (2018)

Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
por: Hitchings, Andrew W, et al.
Publicado: (2016)

Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease
por: Blagev, Denitza P, et al.
Publicado: (2020)

Longevity of pulmonary rehabilitation benefit for chronic obstructive pulmonary disease—health care utilisation in the subsequent 2 years
por: Walsh, James R, et al.
Publicado: (2019)

Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study
por: Vilstrup, Frida, et al.
Publicado: (2023)

Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study
por: Wang, Ye, et al.
Publicado: (2023)

Development of a patient-centred, evidence-based and consensus-based discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease
por: Ospina, Maria B, et al.
Publicado: (2018)

Beta-blockers reduce severe exacerbation in patients with mild chronic obstructive pulmonary disease with atrial fibrillation: a population-based cohort study
por: Lin, Shan-Ju, et al.
Publicado: (2023)

Could patients with chronic obstructive pulmonary disease benefit from renin angiotensin system inhibitors? A meta-analysis
por: Lv, Hongzhen, et al.
Publicado: (2023)

Interventions to standardise hospital care at presentation, admission or discharge or to reduce unnecessary admissions or readmissions for patients with acute exacerbation of chronic obstructive pulmonary disease: a scoping review
por: MacDonell, Rachel, et al.
Publicado: (2020)

Effect of high-flow nasal therapy during acute aerobic exercise in patients with chronic obstructive pulmonary disease after exacerbation: protocol for a randomised, controlled, cross-over trial
por: Prieur, Guillaume, et al.
Publicado: (2017)

An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD
por: Boutou, Afroditi K, et al.
Publicado: (2014)

Plasma sphingolipids in HIV-associated chronic obstructive pulmonary disease
por: Hodgson, Shane, et al.
Publicado: (2017)

Comorbidities and mortality among patients with chronic obstructive pulmonary disease
por: Skajaa, Nils, et al.
Publicado: (2023)

DNA methylation is associated with airflow obstruction in patients living with HIV
por: Hernandez Cordero, Ana I, et al.
Publicado: (2021)

Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD
por: Echevarria, C, et al.
Publicado: (2016)

Small airway determinants of airflow limitation in chronic obstructive pulmonary disease
por: Polosukhin, Vasiliy V, et al.
Publicado: (2021)

Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung
por: Segal, Leopoldo N, et al.
Publicado: (2017)

Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
por: Huang, Jeffrey T-J, et al.
Publicado: (2012)

Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease
por: Jarvis, S, et al.
Publicado: (2014)

Productivity losses in chronic obstructive pulmonary disease: a population-based survey
por: Erdal, Marta, et al.
Publicado: (2014)

Intravenous iron and chronic obstructive pulmonary disease: a randomised controlled trial
por: Santer, Peter, et al.
Publicado: (2020)

Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study
por: McKeever, Tricia M, et al.
Publicado: (2016)

Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study
por: Kjærgaard, Jakob, et al.
Publicado: (2020)

Socio-environmental correlates of physical activity in patients with chronic obstructive pulmonary disease (COPD)
por: Arbillaga-Etxarri, Ane, et al.
Publicado: (2017)

Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?
por: Kusunose, Masaaki, et al.
Publicado: (2017)

Cost-effectiveness of domiciliary non-invasive ventilation in patients with chronic obstructive pulmonary disease
por: Hall, James, et al.
Publicado: (2022)

The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD
por: Echevarria, C, et al.
Publicado: (2017)

Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease
por: Han, Meilan K, et al.
Publicado: (2020)

Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease
por: Vilarinho, Rui, et al.
Publicado: (2022)

Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease
por: Eklöf, Josefin, et al.
Publicado: (2022)

Characteristics of inflammatory phenotypes in patients with chronic obstructive pulmonary disease: a cross-sectional study
por: Wen, Xiang, et al.
Publicado: (2023)

Visual rating assessment of cerebral atrophy and its relationship with cognitive function in chronic obstructive pulmonary disease
por: Savage, Charlotte Claire, et al.
Publicado: (2018)

Evaluation of ‘care bundles’ for patients with chronic obstructive pulmonary disease (COPD): a multisite study in the UK
por: Morton, Katherine, et al.
Publicado: (2019)

The physiology of singing and implications for ‘Singing for Lung Health’ as a therapy for individuals with chronic obstructive pulmonary disease
por: Lewis, Adam, et al.
Publicado: (2021)

Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
por: Pavey, Holly, et al.
Publicado: (2023)

Vitamin D status and chronic obstructive pulmonary disease risk: a prospective UK Biobank study
por: Zhu, Zheng, et al.
Publicado: (2023)

Assessment of lung hyperinflation in occupational chronic obstructive pulmonary disease: a multicentric cross-sectional study
por: de Broucker, Virginie, et al.
Publicado: (2023)

Breathing–swallowing discoordination is associated with frequent exacerbations of COPD
por: Nagami, Shinsuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8khtcu1kmhvbhop2skek07c1ie